Your browser doesn't support javascript.
loading
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
Dinh, Phuong; Graham, J Dinny; Elder, Elisabeth N; Kabir, Masrura; Doan, Tram B; French, James; Meybodi, Farid; Hui, Rina; Wilcken, Nicholas R; Harnett, Paul R; Hsu, Jeremy; Stuart, Kirsty E; Wang, Tim; Ahern, Verity; Brennan, Meagan; Fox, Stephen B; Dear, Rachel F; Lim, Elgene; White, Michelle; Mann, G Bruce; Pathmanathan, Nirmala.
Afiliação
  • Dinh P; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Graham JD; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.
  • Elder EN; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Kabir M; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Doan TB; The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia.
  • French J; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Meybodi F; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Hui R; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Wilcken NR; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Harnett PR; The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia.
  • Hsu J; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Stuart KE; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Wang T; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Ahern V; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Brennan M; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.
  • Fox SB; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.
  • Dear RF; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Lim E; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.
  • White M; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
  • Mann GB; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.
  • Pathmanathan N; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia.
Breast Cancer Res Treat ; 191(3): 501-511, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34853987
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Neoplasias da Mama Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália